Activity ID
15099Expires
September 26, 2026Format Type
LiveCME Credit
1Fee
$0CME Provider: Clinical Care Options, LLC
Description of CME Course
The goal of this activity is to improve the knowledge, competence, and performance of learners in applying diagnostic considerations and assessing new and emerging therapies for the treatment of mood disorders.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Psychiatry and Neurology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
Identify clinical circumstances in which psychotropic
deprescribing should be considered based on current
consensus recommendations
Apply individualized risk-benefit assessment, adherence
evaluation, and shared decision-making when considering
psychotropic deprescribing
Differentiate situations in which medication discontinuation or
simplification is appropriate from those in which continuation,
optimization, or adverse effect management may be preferable
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Academic Medicine, Inpatient, Outpatient, Rural, Urban, VA/Military
